While surgical excision remains the gold standard for treating glomus tumors, GLI1‐altered mesenchymal tumors could respond to targeted therapies, particularly those inhibiting the Hedgehog signaling pathway [45]. The gene discussed is GLI1; the disease is glomus tumor.